$AYI

Acuity Inc. (AYI) Q4 Sales $1.2B, EPS $5.63; FY26 Sales Up 6.8%

Acuity Inc. (AYI) reported Q4 FY26 net sales of $1.2B, GAAP EPS $5.63, and adjusted EPS $5.77. Full-year sales rose 6.8% to $4.6B with GAAP EPS $17.05 and adjusted EPS $19.90. Results included $44.9M tariff refunds and $17.8M special charges.

Original reporting
Published Oct 1, 2026, 10:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 10:13 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Acuity Inc. (AYI) Q4 Sales $1.2B, EPS $5.63; FY26 Sales Up 6.8% — source image
Decision brief

The 30-second read

$AYIBullishHigh
01

Why it matters

The earnings surprise is likely to generate buying pressure, though investors should watch for sustainability of one-time items.

02

Market read

Strong earnings provide a fresh catalyst for AYI, potentially influencing sector sentiment.

03

What to watch

One-time tariff refunds and special charges may not repeat, tempering future growth expectations.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

Acuity Inc. released its Q4 FY26 earnings, highlighting revenue growth and EPS beat.

Company-level read

Ticker impact

$AYIBullishHigh confidence
Context

Acuity Inc. (AYI) reported Q4 FY26 net sales of $1.2B and GAAP EPS $5.63, with full-year sales up 6.8% to $4.6B.

Expected impact

potential upside as market prices in strong earnings

Evidence & confidence

The earnings beat and revenue growth suggest improved profitability, prompting buying interest.

Market effects

Positive earnings may lift the broader medical imaging equipment sector.

U.S. market may see a modest gain in healthcare stocks.

Limited to U.S. and international investors tracking medical device earnings.

Counterpoint

If the earnings beat is already priced in, the stock could face short-term profit taking.

Key entities

  • Acuity Inc.

    Medical imaging equipment manufacturer.

Related articles

$AYIHigh

Acuity Reports Fiscal 2026 Fourth-Quarter and Full-Year Results

ACUITY INC. (DE) (AYI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Press Release Exhibit 99.1 Investor Contact: Charlotte McLaughlin Vice President, Investor Relations (404) 853-1456 investor.relations@acuityinc.com Media Contact: April Appling Senior Vice President, Corporate Communications corporatecommunications@acuityinc.com Acuity Reports F

$AYIHighAI 8/10

Acuity stock rises 2% on fourth-quarter earnings beat

Acuity Inc. (AYI) reported Q4 earnings of $5.77 per share, beating estimates by $0.11, but revenue of $1.24B missed expectations. Shares rose 2.23% in pre-market trading. Full-year sales increased 7% to $4.64B, with adjusted EPS up 11% to $19.90. The Intelligent Spaces segment grew 17% YoY, while Lighting segment sales declined 0.4% YoY.